Harrow (HROW) News Today $36.14 +1.59 (+4.60%) Closing price 04:00 PM EasternExtended Trading$36.26 +0.12 (+0.33%) As of 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Harrow Up Today?Toggle Visibility of Why Is Harrow Up Today?Harrow, Inc. (NASDAQ:HROW) is moving on news of a major biosimilar partnership, updated analyst forecasts and a new securities investigation, driving today’s trading interest. Positive Sentiment: Harrow has secured exclusive U.S. commercialization rights to Samsung Bioepis’s ophthalmology biosimilars BYOOVIZ® and OPUVIZ™.Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States Neutral Sentiment: William Blair forecasts Harrow will report Q2 2025 EPS of $(0.03) while maintaining an Outperform rating.Q2 Earnings Estimate for Harrow Issued By William Blair Negative Sentiment: William Blair cut its FY 2026 EPS estimate for Harrow from $1.35 to $1.30, though it kept an Outperform rating.FY2026 Earnings Forecast for Harrow Issued By William Blair Negative Sentiment: Pomerantz LLP has launched a securities investigation on behalf of Harrow investors regarding potential undisclosed claims.INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROW Posted 55m agoAI Generated. May Contain Errors. HROW Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROWJuly 17 at 10:00 AM | prnewswire.comSamsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United StatesJuly 17 at 7:00 AM | businesswire.comHarrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United StatesJuly 17 at 7:00 AM | businesswire.comFY2026 Earnings Forecast for Harrow Issued By William BlairJuly 17 at 3:49 AM | americanbankingnews.comQ2 Earnings Estimate for Harrow Issued By William BlairJuly 16 at 6:25 AM | marketbeat.comHROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law FirmJuly 15 at 10:38 AM | prnewswire.comFY2026 Earnings Estimate for Harrow Issued By William BlairJuly 15 at 8:23 AM | marketbeat.comHarrow (NASDAQ:HROW) Shares Up 5.7% - What's Next?July 14 at 12:30 PM | marketbeat.comRice Hall James & Associates LLC Has $7.88 Million Holdings in Harrow, Inc. (NASDAQ:HROW)July 14 at 6:36 AM | marketbeat.comCantor Fitzgerald Initiates Coverage on Harrow (NASDAQ:HROW)July 14 at 2:47 AM | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROWJuly 12, 2025 | prnewswire.comCantor Fitzgerald Initiates Coverage of Harrow (HROW) with Overweight RecommendationJuly 11, 2025 | msn.comHarrow jumps as Cantor initiates with Bullish view on conservative outlookJuly 11, 2025 | msn.comHarrow (NASDAQ:HROW) Shares Gap Up - What's Next?July 11, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Coverage Initiated at Cantor FitzgeraldJuly 11, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. ...July 10, 2025 | gurufocus.comHarrow, Inc. (NASDAQ:HROW) Receives $61.40 Average PT from BrokeragesJuly 10, 2025 | americanbankingnews.comHarrow: Immense Upside PotentialJuly 9, 2025 | seekingalpha.comHROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm - MorningstarJuly 7, 2025 | morningstar.comMINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROWJuly 7, 2025 | prnewswire.comHarrow, Inc. (NASDAQ:HROW) Given Average Recommendation of "Buy" by BrokeragesJuly 7, 2025 | marketbeat.comHROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law FirmJuly 6, 2025 | gurufocus.comHROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law FirmJuly 6, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROWJuly 6, 2025 | globenewswire.comWilliam Blair Initiates Coverage of Harrow (HROW) With an Outperform RatingJuly 6, 2025 | msn.comAre Options Traders Betting on a Big Move in Harrow Stock?July 2, 2025 | msn.comHarrow Earns Relative Strength Rating UpgradeJune 30, 2025 | msn.comHarrow, Inc. (NASDAQ:HROW) Shares Bought by Westside Investment Management Inc.June 30, 2025 | marketbeat.comStocks Generating Improved Relative Strength: HarrowJune 26, 2025 | msn.comWe Might See A Profit From Harrow, Inc. (NASDAQ:HROW) SoonJune 26, 2025 | finance.yahoo.comWoodmont Investment Counsel LLC Buys 22,293 Shares of Harrow, Inc. (NASDAQ:HROW)June 21, 2025 | marketbeat.comHarrow Shows Market Leadership With Jump To 83 RS RatingJune 20, 2025 | msn.comAssenagon Asset Management S.A. Sells 99,446 Shares of Harrow, Inc. (NASDAQ:HROW)June 20, 2025 | marketbeat.comHarrow Appoints Mike Biega as Vice President of Investor Relations and CommunicationsJune 19, 2025 | finance.yahoo.comI Am Swimming In Dividends With +7% YieldsJune 13, 2025 | seekingalpha.comHarrow, Inc. (NASDAQ:HROW) Given Consensus Recommendation of "Buy" by BrokeragesJune 12, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Now Covered by Analysts at BTIG ResearchJune 12, 2025 | marketbeat.comWhat is William Blair's Estimate for Harrow Q2 Earnings?June 12, 2025 | marketbeat.comWilliam Blair Initiates Coverage of Harrow (HROW) with Outperform RecommendationJune 12, 2025 | msn.comHarrow wins new Outperform at William Blair after licensing deal for pain drugJune 10, 2025 | msn.comHarrow (NASDAQ:HROW) Shares Gap Up - Still a Buy?June 10, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Coverage Initiated at William BlairJune 10, 2025 | marketbeat.comHarrow acquires U.S. commercial rights to BYQLOVI from Formosa PharmaceuticalsJune 10, 2025 | msn.comHarrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa PharmaceuticalsJune 9, 2025 | prnewswire.comHarrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa PharmaceuticalsJune 9, 2025 | businesswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 29,262 Shares of Harrow, Inc. (NASDAQ:HROW)June 8, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Trading Down 4.7% - Here's WhyJune 5, 2025 | marketbeat.comWellington Management Group LLP Sells 11,951 Shares of Harrow, Inc. (NASDAQ:HROW)June 5, 2025 | marketbeat.comBank of America Corp DE Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW)June 5, 2025 | marketbeat.comNuveen Asset Management LLC Decreases Holdings in Harrow, Inc. (NASDAQ:HROW)June 2, 2025 | marketbeat.com Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address HROW Media Mentions By Week HROW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼0.590.96▲Average Medical News Sentiment HROW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼225▲HROW Articles Average Week Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRISPR Therapeutics News Vaxcyte News Cytokinetics News Metsera News ADMA Biologics News Krystal Biotech News Akero Therapeutics News Avidity Biosciences News PTC Therapeutics News Arcellx News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harrow With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
